Treatment of Refractory Gout With ACTH or Methylprednisolone
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
To clarify the therapeutic effect and safety evaluation of ACTH in refractory gouty arthritis
and special population, and to explore its mechanism of action.